When you buy a secondary interest in a private company, you are not just transacting with a seller. You are also transacting with the company itself, even though it is not at the table. Almost every stockholder agreement or LLC operating agreement contains language requiring the company — and sometimes its board — to approve any transfer of shares or membership interests before it can be recorded on the cap table.

Buyers routinely underweight this step. They negotiate hard on price, move quickly through diligence, and then discover that a consent process has introduced a multi-week delay, a new round of paperwork, or, in rare cases, an outright refusal. Each of those outcomes has a cost.

What company consent actually means

In a direct secondary transaction — where you receive actual shares on the company's cap table — the transfer must be registered in the company's books. That requires the company's transfer agent or secretary to acknowledge the new shareholder. Almost every late-stage private company imposes conditions on that acknowledgment.

The conditions typically include: proof that the buyer is an accredited investor, a completed investment representation letter, sometimes a joinder agreement binding the buyer to existing stockholder agreements, and occasionally a legal opinion that the transfer is exempt from securities registration. All of that is standard. The risk is not in the paperwork itself — it is in the timing and discretion involved.

Ministerial consent
Company reviews documents for completeness only. It must approve if paperwork is correct. Lower risk.
Discretionary consent
Board or an authorized officer can approve or refuse on business judgment grounds. Higher risk.
ROFR-gated consent
Company (or existing shareholders) must first waive or exercise a right of first refusal before transfer proceeds. Timing risk.
Blanket restriction
Transfer is prohibited entirely without board approval for a defined period — common in post-funding lock-up windows. Hard stop until window opens.

The distinction between ministerial and discretionary consent matters enormously. A company with ministerial consent language is constrained — it can push back on documentation but cannot refuse a properly structured transfer without legal exposure. A company with broad discretionary language can decline without explanation and face no contractual consequence.

How to identify which type of consent applies before you transact

The seller's stockholder agreement or LLC operating agreement is the governing document. If you are buying through an SPV (special purpose vehicle), the relevant document is the agreement between the SPV and the company — typically a side letter or the operating agreement the SPV signed when it originally invested. Ask for both.

Look for the transfer restriction section, usually titled 'Restrictions on Transfer' or 'Transfer of Shares.' Read the exact language around company approval. Phrases like 'shall not unreasonably be withheld' are meaningful — they convert discretionary consent into something closer to ministerial. Phrases like 'in its sole discretion' are a warning flag.

Also look for any lock-up provisions tied to recent financing rounds. Companies that closed a primary round in the past six to twelve months sometimes impose voluntary transfer restrictions on existing stockholders as a condition of the round. Those restrictions bind the seller — and they bind the timing of your purchase.

The transfer restriction clause in a stockholder agreement is rarely longer than two paragraphs, but it determines whether your settlement takes 5 days or 60 days. Read it before you price the deal, not after.

The ROFR layer on top of consent

Separate from consent, most cap tables include a right of first refusal (ROFR). This gives the company — and often other existing investors — the right to purchase the shares at your agreed price before you can complete the acquisition. ROFR and consent are related but distinct processes.

When you sign a purchase agreement, the seller typically must notify the company of the proposed transfer, triggering the ROFR period. ROFR periods commonly run 30 to 45 days, though some agreements allow the company to extend. Only once ROFR is formally waived — either affirmatively in writing or through the period expiring without exercise — can the transfer proceed to consent and cap table registration.

Experienced marketplaces initiate ROFR notice as early as possible in the transaction flow, ideally in parallel with completing other documents rather than sequentially. That parallel processing can compress total settlement time by two to three weeks. If a marketplace is running ROFR notice only after all documents are fully executed, ask why.

Three scenarios where consent risk materializes

  1. Company is in a quiet period before a financing round and has instructed its legal team not to process secondary transfers. Your ROFR notice goes unanswered until the round closes — or the company exercises ROFR at your agreed price to absorb shares before a repricing.
  2. The seller's original agreement requires board approval, and the board is unavailable or divided. Transfer sits in limbo for weeks. This is more common at companies with complex governance or a recent change of control at the board level.
  3. The seller is subject to a lock-up from a recent tender offer or secondary transaction the company facilitated. That lock-up was not disclosed clearly, and the transfer restriction clause bars any secondary sale for another six months. Your capital is now committed to a deal that cannot close.

What to ask a marketplace before you commit

Before placing an indication of interest on any secondary listing, ask the marketplace four questions: Has the company's consent process been verified for this seller's specific share class? Has the ROFR period been initiated or is there a confirmed waiver on file? What is the documented settlement timeline for this issuer based on recent transactions? And if consent is delayed or refused, what happens to your deposited funds?

These are not adversarial questions — a reputable marketplace should answer them with specifics, not generalities. Vague answers about 'standard timelines' or 'industry norms' are a signal that consent diligence has not been completed on that specific deal.

At Limen Markets, seller-side supply is confirmed and ROFR is cleared in parallel with document execution, which is how we maintain a 1–5 day settlement window across the 28 issuers on our platform. When you see a listing on our marketplace, the consent pathway for that specific seller has already been assessed.

Pricing consent risk into your offer

If you are transacting on a platform where consent risk is not pre-cleared, you should price it in. A deal with a 45-day uncertain consent process is not the same deal as one with a 5-day ministerial approval, even if the share price is identical. You are taking on time risk, opportunity cost, and the possibility of a fall-through — a transaction that fails to complete — in which case you lose weeks of committed capital and may miss better entry points.

A reasonable framework: estimate the probability that consent is refused or significantly delayed, multiply that probability by the cost of your capital being tied up or the deal falling through entirely, and shade your bid accordingly. On companies with known discretionary consent provisions and active board engagement on secondary activity, that discount can be material.

Consent risk is one of the least-discussed but most frequently encountered friction points in private secondary markets. Buyers who understand it move faster when deals are clean, and price more accurately when they are not. Both are advantages worth having.

Browse current listings with pre-assessed consent pathways on the marketplace, or read more about how ROFR timelines affect net proceeds in our related guide.